Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Aniridic keratopathy is a corneal disease that occurs in people with aniridia, a congenital absence or malformation of the iris. The cornea becomes cloudy due to stem cell deficiency at the limbus. Symptoms include light sensitivity, discomfort, and progressive vision loss. It is chronic and requires specialized management.
read more about aniridic keratopathy ...The condition results from mutations in the PAX6 gene that disrupt corneal epithelial maintenance. Over time, the limbal stem cells fail to regenerate the corneal surface, leading to scarring and vascularization. Repeated inflammation and dryness accelerate decline. Early protective strategies slow the damage.
Limbal stem cells replenish the corneal epithelium after routine wear and tear. When these cells fail, conjunctival tissue grows over the cornea, clouding vision and reducing the smooth optical surface needed for clarity.
You should see your eye doctor if you notice sudden or persistent changes in your vision such as blurriness, flashes of light, floaters, or eye pain. Redness, swelling, or discharge that does not improve with basic care also warrants a checkup. Even if symptoms seem mild, getting a professional evaluation can help detect problems early and prevent complications. Regular eye exams are also important to monitor your overall eye health and keep your vision clear.
Treatment focuses on protecting the ocular surface with preservative free lubricants and avoiding irritation. In advanced cases, limbal stem cell transplantation or keratolimbal grafting can restore clarity. Anti vascular and anti inflammatory therapy supports healing. Lifelong monitoring is needed to preserve function.
While the genetic defect cannot be prevented, early surface care delays onset. Avoiding dry environments and controlling inflammation help. Family counseling assists in understanding inheritance. Gene based therapies are under research.
Individuals with congenital aniridia carry the greatest risk. Corneal trauma or surgery can worsen progression. Regular exams from childhood onward allow early detection. Protective eyewear and moisture support daily comfort.
Is transplant curative? It can restore clarity but recurrence may occur.
Can it cause blindness? Severe scarring may limit vision but support reduces impact.
Is it inherited? Yes, often autosomal dominant via PAX6 mutation.
Tripathy, K., & Chawla, R. (2023). Aniridia (includes aniridia-associated keratopathy). StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK538133/
van Velthoven, A. J. H., et al. (2023). Future Directions in Managing Aniridia-Associated Keratopathy. Survey of Ophthalmology. https://www.surveyophthalmol.com/article/S0039-6257%2823%2900066-8/fulltext
Kaye, A. E., et al. (2025). Characterising Corneal Changes in Aniridia-Related Keratopathy. BMJ Open Ophthalmology. https://bmjophth.bmj.com/content/10/1/e002300
National Organization for Rare Disorders. (2024). Aniridia. NORD Rare Disease Database. https://rarediseases.org/rare-diseases/aniridia/
Orphanet. (n.d.). Isolated Aniridia. Orphanet. https://www.orpha.net/en/disease/detail/250923